France
About bioMérieux S.A.
bioMérieux S.A. is a global leader in in vitro diagnostic solutions, specializing in the detection and management of infectious diseases. The company operates across the Americas, Europe, the Middle East, Africa, and the Asia Pacific.
Key Products & Solutions
- CHROMID RANGE – Chromogen culture media for bacterial identification.
- RAPIDEC CARBA NP – Biochemical test for carbapenemase-producing bacteria detection.
- BACT/ALERT VIRTUO & 3D – Blood sample culture systems.
- BIOFIRE & BIOFIRE SPOTFIRE – Multiplex PCR and point-of-care testing systems.
- VITEK MS & VITEK 2 – Mass spectrometry and automated antimicrobial susceptibility testing.
- API RANGE – Standardized ID strips for microbial identification.
- ETEST Gradient – Method for antibiotic susceptibility testing.
- BIOMERIEUX EPISEQ CS – Whole genome sequencing for epidemiologic monitoring.
- VIDASB·R·A·H·M·S PCT™ – Sepsis biomarker testing.
- Biomérieux Vision Suite – Diagnostic decision-support software.
- ARGENE Monoplex PCR – Targeted pathogen detection.
- NUCLISENS & EMAG – Molecular biology automation and extraction systems.
- GENE-UP & VERIFLOW – Food industry microorganism detection.
Industries Served
The company provides solutions for:
- Clinical and hospital laboratories
- Physicians and blood banks
- Veterinary diagnostics
- Industrial control laboratories
Company Background
Founded in 1963 as B-D Mérieux, bioMérieux S.A. is headquartered in Marcy-l'Étoile, France. It operates as a subsidiary of Institut Mérieux SA.
